Pulmonary Neoplasms: Clinical Trials

2 trials for Pulmonary Neoplasms, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 completed. 2 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Active not recruiting 1, Completed 1
Phase 22Active not recruiting 1, Completed 1

Follow Pulmonary Neoplasms: new trials by email Literature Review of Pulmonary Neoplasms trials Research Report on Pulmonary Neoplasms

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation
JDQ443, TNO155, tislelizumab - KRAS G12C Mutant Solid Tumors, Carcinoma, Non-Small-Cell Lung
Phase 1 / Phase 2Active not recruitingNovartis Pharmaceuticals3442021-02-242026-10-19
RejuvenAir Lobectomy for Safety and Histology
RejuvenAir - Lung Neoplasms, Pulmonary Neoplasms
Phase 1 / Phase 2CompletedCSA Medical, Inc.62015-08-012017-05-11

Narrower conditions

Lung Neoplasms (2)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Colorectal Neoplasms (1)  ·  Neoplasm Metastasis (1)

Broader conditions

Lung Diseases (2)  ·  Neoplasms (2)  ·  Neoplasms by Site (2)  ·  Respiratory Tract Diseases (2)  ·  Respiratory Tract Neoplasms (2)  ·  Thoracic Neoplasms (2)  ·  Bronchial Neoplasms (1)  ·  Carcinoma, Bronchogenic (1)  ·  Colonic Diseases (1)  ·  Digestive System Diseases (1)  ·  Digestive System Neoplasms (1)  ·  Gastrointestinal Diseases (1)  ·  Gastrointestinal Neoplasms (1)  ·  Intestinal Diseases (1)  ·  Intestinal Neoplasms (1)

Interventions

JDQ443 (1)  ·  tislelizumab (1)

Sponsors

CSA Medical, Inc. (1)  ·  Novartis Pharmaceuticals (1)

Countries

Canada (2)  ·  Australia (1)  ·  Belgium (1)  ·  China (1)  ·  Denmark (1)  ·  France (1)  ·  Germany (1)  ·  Hong Kong (1)  ·  Italy (1)  ·  Japan (1)  ·  Netherlands (1)  ·  Singapore (1)  ·  South Korea (1)  ·  Spain (1)  ·  Taiwan (1)

Top investigators

Kashif Irshad, MDCM, MSc (1)

Results publications

PMID 36399068